Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Apr 21, 2018, 11:30 ET Mylan Presents Equivalence Data on Glatiramer Acetate Compared to Copaxone® at American Academy of Neurology 70th Annual Meeting

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced three scientific abstracts from the Glatiramer Acetate development program...


Apr 20, 2018, 18:30 ET New Study Highlights Importance of R&D Talent Development Initiatives in Pharmaceutical and Technology Companies

Across industries, an organization's research and development (R&D) function plays an important role in converting innovative ideas into...


Apr 20, 2018, 14:50 ET Lilly Reports Additional Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer

Eli Lilly and Company (NYSE: LLY) today announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE...


Apr 20, 2018, 09:00 ET Indivior Announces New Drug Submission to Health Canada for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Moderate to Severe Opioid Use Disorder

Health Canada Grants Priority Review Designation for SUBLOCADE™ Indivior PLC (LON: INDV) today announced that it has filed a New Drug...


Apr 20, 2018, 08:30 ET CSL Behring, Leader in Rare Diseases, Showcases Innovations in Neuromuscular Medicine (NMM) at the 2018 American Academy of Neurology Annual Meeting

Global biotherapeutics leader CSL Behring today announced that it will host an Industry Therapeutic Update at the 2018 annual meeting of the...


Apr 20, 2018, 08:15 ET Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance

Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian...


Apr 20, 2018, 08:01 ET Allergan Showcases Leadership in Neurosciences with 25 Presentations at the American Academy of Neurology Annual Meeting in Los Angeles

Allergan plc (NYSE: AGN), a leading global pharmaceutical company announced today that the company will share 25 presentations at the 70th Annual...


Apr 20, 2018, 08:00 ET Myovant Sciences and PERIOD. Inc. Launch Partnership Focused on Empowering Women to Elevate the Conversation Around Period Health

Myovant Sciences (NYSE: MYOV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for...


Apr 20, 2018, 08:00 ET Senomyx Sets First Quarter 2018 Earnings Release Date for Thursday, April 26, 2018 at 4:05 p.m. ET

Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor...


Apr 20, 2018, 07:00 ET Transparency Life Science Founder Tomasz Sablinski Tops "Champions of Change" in The Medicine Maker's 2018 Power List

Transparency Life Sciences (TLS) founder and Chief Executive Officer, Tomasz Sablinski, MD, PhD, has been ranked the most prominent of the...


Apr 20, 2018, 06:50 ET Technical Perspectives on Biotech Stocks -- Alnylam Pharma, Amgen, Amicus Therapeutics, and Ampio Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ALNY, AMGN, FOLD, and...


Apr 20, 2018, 05:38 ET NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that its mitochondrial myopathy project, NVP025, has been...


Apr 20, 2018, 05:30 ET Super Model-Turned-Super Mogul Kathy Ireland Interviews Anpac Bio CEO For 'Worldwide Business'

Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, was interviewed this week by...


Apr 20, 2018, 02:55 ET NeuroVive's Board Members, Senior Executives and Employees Will Subscribe Units in the Ongoing Rights Issue

In the current rights issue in NeuroVive, the Board, Senior Executives and employees have undertaken to subscribe for at least 191,200 units...


Apr 19, 2018, 19:38 ET ESSA Pharma Inc. Announces Share Consolidation

HOUSTON and VANCOUVER, April 19, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage...


Apr 19, 2018, 19:31 ET Rigel Announces Pricing Of Public Offering Of Common Stock

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of its previously announced underwritten public offering of 16,000,000...


Apr 19, 2018, 16:05 ET Theravance Biopharma Highlights Landmark IMPACT Study Published in NEJM Showing Significant Benefits of Trelegy Ellipta for COPD Patients

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today highlighted the publication in the New England Journal of Medicine (NEJM)...


Apr 19, 2018, 16:00 ET Amgen Announces Webcast Of 2018 First Quarter Financial Results

Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2018 financial results on Tuesday, April 24, 2018, after the close of the...


Apr 19, 2018, 14:19 ET Allergan Does Not Intend to Make an Offer for Shire plc; Strategic Review Continues

In order to comply with the requirements of the UK Takeover Code, Allergan announced that it does not intend to make an offer for Shire. Allergan...


Apr 19, 2018, 14:02 ET The Lancet publishes results demonstrating adjuvanted quadrivalent influenza vaccine provides significantly greater efficacy in children 6 through 23 months

Seqirus, a CSL company (ASX: CSL) and a leading innovator in influenza vaccines, today announced that The Lancet Respiratory Medicine published...


Apr 19, 2018, 13:29 ET Le changement de l'actionnariat d'Esaote a été complété

Esaote SpA, entreprise leader dans le secteur des équipements biomédicaux - en particulier dans les domaines de l'échographie, de l'IRM dédiée et...


Apr 19, 2018, 13:25 ET Se completa el cambio de propiedad de Esaote

Esaote SpA, líder dentro del sector del equipamiento biomédico - en concreto las áreas de ultrasonidos, IRM especifica y software para gestión de...


Apr 19, 2018, 13:23 ET Eigentümerwechsel von Esaote abgeschlossen

Esaote SpA, führend auf dem Gebiet der biomedizinischen Geraete − insbesondere in den Bereichen Ultraschall, spezieller MRI und Software zur...


Apr 19, 2018, 13:20 ET The Change of Esaote's Ownership has Been Completed

Esaote SpA, leader in the biomedical equipment sector - in particular the areas of ultrasound, dedicated MRI and software for managing the...


Apr 19, 2018, 13:18 ET Real-World Data From Surveillance Study Confirms Excellent Safety And Tolerability Profile Of IBgard® At 24 Months

IM HealthScience® (IMH) today announced favorable results from its Irritable Bowel Syndrome Safety Update at 24 Months (IBSSU-24), a real-world...